Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Mental health liaison in a regional burns unit-Past, present and future.

Adams C, Locke C, Warner J.

Burns. 2019 Sep;45(6):1375-1378. doi: 10.1016/j.burns.2019.04.005. Epub 2019 May 4.

PMID:
31060761
2.

Levodopa-carbidopa intestinal gel high concentration formulation is clinically bioequivalent to commercial formulation.

Rosebraugh M, Kalluri HV, Liu W, Locke C, Sidhu D, Han JH, Benesh J.

Pharmacol Res Perspect. 2019 Apr;7(2):e00473. doi: 10.1002/prp2.473.

3.

Dystrobrevin is required postsynaptically for homeostatic potentiation at the Drosophila NMJ.

Jantrapirom S, Nimlamool W, Temviriyanukul P, Ahmadian S, Locke CJ, Davis GW, Yamaguchi M, Noordermeer JN, Fradkin LG, Potikanond S.

Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1579-1591. doi: 10.1016/j.bbadis.2019.03.008. Epub 2019 Mar 21.

PMID:
30904609
4.

Admittedly Simple? The Quest for Clarity in Medicare Claims Data.

Engel JZ, Locke CF.

J Hosp Med. 2019 Feb;14(2):129-130. doi: 10.12788/jhm.3135.

PMID:
30785423
5.

Making inference with messy (citizen science) data: when are data accurate enough and how can they be improved?

Clare JDJ, Townsend PA, Anhalt-Depies C, Locke C, Stenglein JL, Frett S, Martin KJ, Singh A, Van Deelen TR, Zuckerberg B.

Ecol Appl. 2019 Mar;29(2):e01849. doi: 10.1002/eap.1849. Epub 2019 Feb 19.

PMID:
30656779
6.

Race and Hepatitis C Care Continuum in an Underserved Birth Cohort.

Kim NJ, Locke CJ, Park H, Magee C, Bacchetti P, Khalili M.

J Gen Intern Med. 2019 Oct;34(10):2005-2013. doi: 10.1007/s11606-018-4649-6. Epub 2018 Sep 20.

PMID:
30238404
7.

Clients' Perspectives of the Effectiveness of Home Modification Recommendations by Occupational Therapists.

Lau GWC, Yu ML, Brown T, Locke C.

Occup Ther Health Care. 2018 Jul;32(3):230-250. doi: 10.1080/07380577.2018.1491085. Epub 2018 Sep 5.

PMID:
30183439
8.

Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics of Alicapistat, a Selective Inhibitor of Human Calpains 1 and 2 for the Treatment of Alzheimer Disease: An Overview of Phase 1 Studies.

Lon HK, Mendonca N, Goss S, Othman AA, Locke C, Jin Z, Rendenbach-Mueller B.

Clin Pharmacol Drug Dev. 2019 Apr;8(3):290-303. doi: 10.1002/cpdd.598. Epub 2018 Jul 27.

PMID:
30052328
9.

Activation of EphB2 Forward Signaling Enhances Memory Consolidation.

Alapin JM, Dines M, Vassiliev M, Tamir T, Ram A, Locke C, Yu J, Lamprecht R.

Cell Rep. 2018 May 15;23(7):2014-2025. doi: 10.1016/j.celrep.2018.04.042.

10.

Correction: Optogenetic activation of EphB2 receptor in dendrites induced actin polymerization by activating Arg kinase.

Locke C, Machida K, Tucker CL, Wu Y, Yu J.

Biol Open. 2018 Apr 23;7(4). pii: bio034694. doi: 10.1242/bio.034694. No abstract available.

11.

Methotrexate Dose in Patients With Early Rheumatoid Arthritis Impacts Methotrexate Polyglutamate Pharmacokinetics, Adalimumab Pharmacokinetics, and Efficacy: Pharmacokinetic and Exposure-response Analysis of the CONCERTO Trial.

Goss SL, Klein CE, Jin Z, Locke CS, Rodila RC, Kupper H, Burmester GR, Awni WM.

Clin Ther. 2018 Feb;40(2):309-319. doi: 10.1016/j.clinthera.2018.01.002.

PMID:
29402521
12.

Optogenetic activation of EphB2 receptor in dendrites induced actin polymerization by activating Arg kinase.

Locke C, Machida K, Tucker CL, Wu Y, Yu J.

Biol Open. 2017 Dec 15;6(12):1820-1830. doi: 10.1242/bio.029900. Erratum in: Biol Open. 2018 Apr 23;7(4):. Tucker CL [added].

13.

Assessment of Medical-Surgical Patients' Perception of Hospital Noises and Reported Ability to Rest.

Locke CL, Pope DS.

Clin Nurse Spec. 2017 Sep/Oct;31(5):261-267. doi: 10.1097/NUR.0000000000000321.

PMID:
28806232
14.

Hospitalizations With Observation Services and the Medicare Part A Complex Appeals Process at Three Academic Medical Centers.

Sheehy AM, Engel JZ, Locke CFS, Weissburg DJ, Eldridge K, Caponi B, Deutschendorf A.

J Hosp Med. 2017 Apr;12(4):251-255. doi: 10.12788/jhm.2720.

PMID:
28411297
15.

Trajectory optimization in radiotherapy using sectioning (TORUS).

Locke CB, Bush KK.

Med Phys. 2017 Jul;44(7):3375-3392. doi: 10.1002/mp.12270. Epub 2017 Jun 16.

PMID:
28397968
16.

Hypothalamic-pituitary-adrenal axis and depression symptom effects of an arginine vasopressin type 1B receptor antagonist in a one-week randomized Phase 1b trial.

Katz DA, Locke C, Greco N, Liu W, Tracy KA.

Brain Behav. 2017 Feb 9;7(3):e00628. doi: 10.1002/brb3.628. eCollection 2017 Mar.

17.

Levodopa-Carbidopa Intestinal Gel Pharmacokinetics: Lower Variability than Oral Levodopa-Carbidopa.

Othman AA, Rosebraugh M, Chatamra K, Locke C, Dutta S.

J Parkinsons Dis. 2017;7(2):275-278. doi: 10.3233/JPD-161042.

18.

Bringing analysis of gender and social-ecological resilience together in small-scale fisheries research: Challenges and opportunities.

Kawarazuka N, Locke C, McDougall C, Kantor P, Morgan M.

Ambio. 2017 Mar;46(2):201-213. doi: 10.1007/s13280-016-0814-5. Epub 2016 Sep 10. Review.

19.
20.

Learning From Lawsuits: Using Malpractice Claims Data to Develop Care Transitions Planning Tools.

Arbaje AI, Werner NE, Kasda EM, Wu AW, Locke CF, Aboumatar H, Paine LA, Leff B, Davis RO, Boonyasai R.

J Patient Saf. 2016 Jun 10. [Epub ahead of print]

PMID:
27294592
21.

Single-Dose Interaction Study of the Arginine Vasopressin Type 1B Receptor Antagonist ABT-436 and Alcohol in Moderate Alcohol Drinkers.

Katz DA, Locke C, Liu W, Zhang J, Achari R, Wesnes KA, Tracy KA.

Alcohol Clin Exp Res. 2016 Apr;40(4):838-45. doi: 10.1111/acer.12996. Epub 2016 Mar 10.

PMID:
26969417
22.

The Authors Reply I, "patient financial responsibility for observation care" and "observation versus inpatient hospitalization: What do medicare beneficiaries pay?".

Sheehy AM, Boswell J, Caponi B, Locke CF.

J Hosp Med. 2016 Jun;11(6):457-8. doi: 10.1002/jhm.2563. Epub 2016 Feb 23. No abstract available.

PMID:
26914412
23.
24.

Clinical safety and hypothalamic-pituitary-adrenal axis effects of the arginine vasopressin type 1B receptor antagonist ABT-436.

Katz DA, Liu W, Locke C, Dutta S, Tracy KA.

Psychopharmacology (Berl). 2016 Jan;233(1):71-81. doi: 10.1007/s00213-015-4089-5. Epub 2015 Sep 26.

PMID:
26407603
25.

Observation versus inpatient hospitalization: What do Medicare beneficiaries pay?

Sheehy AM, Boswell J, Caponi B, Locke CF.

J Hosp Med. 2015 Nov;10(11):760-1. doi: 10.1002/jhm.2440. Epub 2015 Aug 20. No abstract available.

PMID:
26291040
26.

Frac Sand Mines Are Preferentially Sited in Unzoned Rural Areas.

Locke C.

PLoS One. 2015 Jul 2;10(7):e0131386. doi: 10.1371/journal.pone.0131386. eCollection 2015.

27.

The Authors Reply: "Changes to inpatient versus outpatient hospitalization: Medicare's 2-midnight rule".

Locke C, Sheehy AM.

J Hosp Med. 2015 Aug;10(8):561. doi: 10.1002/jhm.2372. Epub 2015 Jun 19. No abstract available.

PMID:
26097201
28.

Effects of a T-type calcium channel blocker, ABT-639, on spontaneous activity in C-nociceptors in patients with painful diabetic neuropathy: a randomized controlled trial.

Serra J, Duan WR, Locke C, Solà R, Liu W, Nothaft W.

Pain. 2015 Nov;156(11):2175-83. doi: 10.1097/j.pain.0000000000000249.

PMID:
26035253
29.

Recovery Audit Contractor audits and appeals at three academic medical centers.

Sheehy AM, Locke C, Engel JZ, Weissburg DJ, Mackowiak S, Caponi B, Gangireddy S, Deutschendorf A.

J Hosp Med. 2015 Apr;10(4):212-9. doi: 10.1002/jhm.2332. Epub 2015 Feb 24.

PMID:
25707363
30.

Changes to inpatient versus outpatient hospitalization: Medicare's 2-midnight rule.

Locke C, Sheehy AM, Deutschendorf A, Mackowiak S, Flansbaum BE, Petty B.

J Hosp Med. 2015 Mar;10(3):194-201. doi: 10.1002/jhm.2312. Epub 2014 Dec 31. Review.

PMID:
25557865
31.

Controlled exosome release from the retinal pigment epithelium in situ.

Locke CJ, Congrove NR, Dismuke WM, Bowen TJ, Stamer WD, McKay BS.

Exp Eye Res. 2014 Dec;129:1-4. doi: 10.1016/j.exer.2014.10.010. Epub 2014 Oct 11. Review.

PMID:
25311167
32.

Observations and models of highly intermittent phytoplankton distributions.

Mandal S, Locke C, Tanaka M, Yamazaki H.

PLoS One. 2014 May 2;9(5):e94797. doi: 10.1371/journal.pone.0094797. eCollection 2014.

33.

Breaking up prolonged sitting with light-intensity walking improves postprandial glycemia, but breaking up sitting with standing does not.

Bailey DP, Locke CD.

J Sci Med Sport. 2015 May;18(3):294-8. doi: 10.1016/j.jsams.2014.03.008. Epub 2014 Mar 20.

PMID:
24704421
34.

Ultrasound-guided needle localization to aid foreign body removal in pediatric patients.

Nwawka OK, Kabutey NK, Locke CM, Castro-Aragon I, Kim D.

J Foot Ankle Surg. 2014 Jan-Feb;53(1):67-70. doi: 10.1053/j.jfas.2013.09.006. Epub 2013 Nov 13.

PMID:
24239426
35.

The H3 antagonist ABT-288 is tolerated at significantly higher exposures in subjects with schizophrenia than in healthy volunteers.

Othman AA, Haig G, Florian H, Locke C, Gertsik L, Dutta S.

Br J Clin Pharmacol. 2014 Jun;77(6):965-74. doi: 10.1111/bcp.12281.

36.

Peripheral and central nervous system inhibition of 11β-hydroxysteroid dehydrogenase type 1 in man by the novel inhibitor ABT-384.

Katz DA, Liu W, Locke C, Jacobson P, Barnes DM, Basu R, An G, Rieser MJ, Daszkowski D, Groves F, Heneghan G, Shah A, Gevorkyan H, Jhee SS, Ereshefsky L, Marek GJ.

Transl Psychiatry. 2013 Aug 27;3:e295. doi: 10.1038/tp.2013.67.

37.

The joint modeling of drug and positive control effects to estimate sample size and power in crossover "thorough" QT/QTc studies.

Hosmane B, Locke C, Chiu YL.

J Biopharm Stat. 2013;23(4):871-80. doi: 10.1080/10543406.2013.789890.

PMID:
23786591
38.

Crossover versus parallel designs: dose-escalation design comparisons for first-in-human studies.

Yan Z, Hosmane B, Locke C.

J Biopharm Stat. 2013;23(4):804-17. doi: 10.1080/10543406.2013.792827.

PMID:
23786490
39.

Land management restrictions and options for change in perpetual conservation easements.

Rissman A, Bihari M, Hamilton C, Locke C, Lowenstein D, Motew M, Price J, Smail R.

Environ Manage. 2013 Jul;52(1):277-88. doi: 10.1007/s00267-013-0091-z. Epub 2013 Jun 20.

PMID:
23784713
40.

Clinical Safety, Pharmacokinetics, and Pharmacodynamics of the 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor ABT-384 in Healthy Volunteers and Elderly Adults.

Liu W, Katz DA, Locke C, Daszkowski D, Wang Y, Rieser MJ, Awni W, Marek GJ, Dutta S.

Clin Pharmacol Drug Dev. 2013 Apr;2(2):133-51. doi: 10.1002/cpdd.5. Epub 2013 Feb 21.

PMID:
27121668
41.

Pharmacokinetics of levodopa, carbidopa, and 3-O-methyldopa following 16-hour jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients.

Nyholm D, Odin P, Johansson A, Chatamra K, Locke C, Dutta S, Othman AA.

AAPS J. 2013 Apr;15(2):316-23. doi: 10.1208/s12248-012-9439-1. Epub 2012 Dec 11.

42.

Direct comparison of a Ca+ single-ion clock against a Sr lattice clock to verify the absolute frequency measurement.

Matsubara K, Hachisu H, Li Y, Nagano S, Locke C, Nogami A, Kajita M, Hayasaka K, Ido T, Hosokawa M.

Opt Express. 2012 Sep 24;20(20):22034-41. doi: 10.1364/OE.20.022034.

PMID:
23037353
43.

Safety, tolerability and pharmacokinetics of the histamine H3 receptor antagonist, ABT-288, in healthy young adults and elderly volunteers.

Othman AA, Haig G, Florian H, Locke C, Zhang J, Dutta S.

Br J Clin Pharmacol. 2013 May;75(5):1299-311. doi: 10.1111/j.1365-2125.2012.04472.x.

44.

Feminine charm: an experimental analysis of its costs and benefits in negotiations.

Kray LJ, Locke CC, Van Zant AB.

Pers Soc Psychol Bull. 2012 Oct;38(10):1343-57. Epub 2012 Jul 19.

PMID:
22821088
45.

An oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UV(B)-inflamed and normal skin.

Schaffler K, Reeh P, Duan WR, Best AE, Othman AA, Faltynek CR, Locke C, Nothaft W.

Br J Clin Pharmacol. 2013 Feb;75(2):404-14. doi: 10.1111/j.1365-2125.2012.04377.x.

46.

Evaluating an insulin infusion protocol in an acute care setting.

Locke C, McEuen J, Felder RS, Lesselroth B, Barrett TW, Stevens B, Pope DS.

Clin Nurse Spec. 2011 Sep-Oct;25(5):237-43.

PMID:
22649844
47.

Single-crystal cubic silicon carbide: an in vivo biocompatible semiconductor for brain machine interface devices.

Frewin CL, Locke C, Saddow SE, Weeber EJ.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:2957-60. doi: 10.1109/IEMBS.2011.6090582.

PMID:
22254961
48.
49.

Experiences of chronic stress one year after the Gulf oil spill.

Werner D, Locke C.

Int J Emerg Ment Health. 2012;14(4):239-45.

PMID:
23980488
50.

Qualitative life course methodologies: critical reflections from development studies.

Locke C, Lloyd-Sherlock P.

Dev Change. 2011;42(5):1131-52.

PMID:
22175084

Supplemental Content

Support Center